Raul Rodriguez

Verkställande Direktör på RIGEL PHARMACEUTICALS, INC.

Förmögenhet: 9 M $ per 2026-05-31

65 år

Health Technology

Consumer Services

Profil

Raul R.
Rodriguez is currently President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. since 2014, with employment at the company starting in 2000.
Formerly, Mr. Rodriguez was Executive Director-Business Development at Scios, Inc. from 1994 to 1997 and Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Education includes graduate studies at the University of Illinois, an MBA from Stanford Graduate School of Business, and undergraduate studies at Harvard College.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
RIGEL PHARMACEUTICALS, INC. 1,51 %	2026-06-17	279 593 ( 1,51 % )	9 M $	2026-05-31

Aktiva positioner av Raul Rodriguez

Företag	Position	Start
RIGEL PHARMACEUTICALS, INC.	Verkställande Direktör	2014-11-21

Alla aktiva positioner av Raul Rodriguez

Tidigare kända positioner av Raul Rodriguez

Företag	Position	Slut
Ontogeny, Inc. Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases	Verksamhetschef	2000-03-01
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals	Företagsledare/Principal	1997-03-01

Se detaljerna i Raul Rodriguezs erfarenhet

Raul Rodriguezs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Raul Rodriguezs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	6
Scios, Inc. Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals	Health Technology
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs	Health Technology
Ontogeny, Inc. Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases	Health Technology
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stanford Graduate School of Business Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services